切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2018, Vol. 12 ›› Issue (01) : 36 -39. doi: 10.3877/cma.j.issn.1674-0793.2018.01.009

所属专题: 文献

论著

甲状腺乳头状癌术中纳米炭示踪对淋巴结清扫及甲状旁腺保护的临床意义
南润玲1, 尚培中1,(), 王金1, 张克俭1, 王铁山1, 聂阿娜1, 李艳艳1, 张伟1, 胡玮1   
  1. 1. 075000 张家口,解放军第251医院普通外科
  • 收稿日期:2017-10-01 出版日期:2018-02-01
  • 通信作者: 尚培中

Clinical significance of carbon nanoparticles tracing in lymph node dissection and parathyroid gland protection in papillary thyroid carcinoma surgery

Runling Nan1, Peizhong Shang1,(), Jin Wang1, Kejian Zhang1, Tieshan Wang1, A’na Nie1, Yanyan Li1, Wei Zhang1, Wei Hu1   

  1. 1. Department of General Surgery, the 251st Hospital of PLA, Zhangjiakou 075000, China
  • Received:2017-10-01 Published:2018-02-01
  • Corresponding author: Peizhong Shang
  • About author:
    Corresponding author: Shang Peizhong, Email:
引用本文:

南润玲, 尚培中, 王金, 张克俭, 王铁山, 聂阿娜, 李艳艳, 张伟, 胡玮. 甲状腺乳头状癌术中纳米炭示踪对淋巴结清扫及甲状旁腺保护的临床意义[J/OL]. 中华普通外科学文献(电子版), 2018, 12(01): 36-39.

Runling Nan, Peizhong Shang, Jin Wang, Kejian Zhang, Tieshan Wang, A’na Nie, Yanyan Li, Wei Zhang, Wei Hu. Clinical significance of carbon nanoparticles tracing in lymph node dissection and parathyroid gland protection in papillary thyroid carcinoma surgery[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2018, 12(01): 36-39.

目的

探讨甲状腺乳头状癌术中纳米炭混悬注射液淋巴示踪对淋巴结清扫及甲状旁腺保护的临床意义。

方法

回顾性分析解放军第251医院2014年5月至2016年12月收治80例甲状腺乳头状癌患者临床资料,将40例注射纳米炭混悬注射液的患者作为研究组,40例常规手术患者作为对照组。比较两组淋巴结检出数目及甲状旁腺的损伤情况。

结果

①淋巴结总数:研究组438枚,平均( 9.4 ± 2.3)枚/例;对照组332枚,平均(5.7± 1.7)枚/例;②微淋巴结检出数:研究组102枚,平均(3.3 ± 2.3)枚/例,对照组40枚,平均(1.5± 1.1)枚/例;③转移淋巴结数:研究组290枚,平均(7.2± 2.6)枚/例;对照组155枚,平均(3.8± 1.7)枚/例;上述三组数据两组间对比差异均有统计学意义(t=6.59、4.89、13.28,P=0.01、0.02、0.00);④术后病理标本中甲状旁腺组织检出率:研究组为5.0%(2/40),明显低于对照组的22.5%(9/40),差异有统计学意义(χ2=7.04,P=0.00)。

结论

甲状腺乳头状癌根治术中通过纳米炭混悬注射液对颈部淋巴通路进行标记及定位,可有效提高淋巴结的检获数,增强手术的精准性和彻底性。同时,通过其负显影作用有助于减少甲状旁腺损伤。

Objective

To investigate the clinical significance of carbon nanoparticles suspension injection tracing in lymph node dissection and parathyroid gland protection in papillary thyroid carcinoma surgery.

Methods

The clinical data of eighty cases with papillary thyroid carcinoma in the 251st Hospital of PLA from May 2014 to December 2016 were retrospectively analyzed, forty patients with carbon nanoparticles suspension injection regarded as the study group, and forty with conventional operation regarded as the control group. The number of lymph nodes and postoperative pathology specimens with or without parathyroid glands tissue were compared between the two groups.

Results

(1) Total number of lymph nodes: in study group 438 lymph nodes were detected, with an average of (9.4±2.3) per case and in control group there were 332, with an average of (5.7±1.7) per case. (2) Tiny lymph nodes: 102 tiny lymph nodes were found in study group, with an average of (3.3±2.3) per case and in control group there were 40, with an average of (1.5±1.1) per case. (3) Metastatic lymph nodes: in study group 290 metastatic lymph nodes were detected, with an average of (7.2±2.6) per case and in control group there were 155, with an average of (3.8±1.7) per case. The differences between the two groups were statistically significant (t=6.59, 4.89, 13.28, P=0.01, 0.02, 0.00). (4) The detection rate of parathyroid glands in postoperative pathological specimens: the incidence of parathyroid glands in postoperative pathological specimens was 5.0% (2/40) in study group and 22.5% (9/40) in control group, the difference was statistically significant (χ2=7.04, P=0.00).

Conclusions

In papillary thyroid carcinoma surgery, the lymph marking and locating with carbon nanoparticles suspension injection can increase the rate of detected neck lymph nodes, enhance the accuracy and thoroughness of operation. Meanwhile, it can reduce the damage of parathyroid gland by negative development.

表1 研究组与对照组检获淋巴结总数、直径、转移率比较
图4 喉返神经未染色
[1]
尚培中,柳勇,南润玲. 甲状腺乳头状癌的诊断与治疗[J]. 中国现代普通外科进展, 2015, 18(10): 833-836.
[2]
尚培中,张进权,柳勇. 分化型甲状腺癌的诊断与规范化手术治疗[J]. 临床误诊误治, 2015, 28(6): 44-47.
[3]
薛文丹,刑孔丽,李小清. 超声诊断甲状腺良恶性结节的声像特征及临床价值[J/CD].中华普通外科学文献(电子版), 2017, 11(3): 187-190.
[4]
南润玲,尚培中,谷化平, 等. 半乳糖凝集素3、细胞角蛋白19及甲状腺过氧化物酶在甲状腺乳头状癌中的表达及意义[J/CD]. 中华临床医师杂志(电子版), 2013, 7(6): 2381-2384.
[5]
龙淼云,梁施华,安富丽, 等. 钳式LigaSure和传统方法在开放性甲状腺全切除术中的应用比较[J/CD]. 中华普通外科学文献(电子版), 2015, 9(4): 316-318.
[6]
李龙山,孙鹏飞. 分化型甲状腺癌治疗的现状和进展[J/CD]. 中华普通外科学文献(电子版), 2017, 11(3): 208-212.
[7]
余炯标,区奕猛,罗永平, 等. 逆行切除法在甲状腺腺叶全切除术中的应用[J/CD]. 中华普通外科学文献(电子版), 2017, 11(1): 48-50.
[8]
Xia S, Wang C, Postma EL, et al. Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis[J]. Onco Targets Ther, 2017, 22 (10): 1743-1755.
[9]
周学兵,王炜,程锁利. 乳头状甲状腺癌颈部淋巴结转移规律分析[J]. 当代医学, 2012, 18 (14): 103-104.
[10]
Musholt TJ. Classification of locoregional lymph nodes in medullary and papillary thyroid cancer[J]. Langenbecks Arch Surg, 2014, 399 (2): 217-223.
[11]
尚培中,南润玲,王金, 等. 唾液酸化Lewis X和半乳糖凝集素-3表达与甲状腺乳头状癌浸润转移的关系[J]. 亚州肿瘤科病例研究, 2017, 6(4): 33-39.
[12]
Salari B, Hammon RJ, Kamani D, et al. Staged surgery for advanced thyroid cancers: safety and oncologic outcomes of neural monitored surgery[J]. Otolaryngol Head Neck Surg, 2017, 156(5): 816- 821.
[13]
翟新法,龚建军,王蓉, 等. 纳米炭在甲状腺癌手术中识别甲状旁腺的应用分析[J]. 吉林医学, 2016, 37(12): 2972-2973.
[14]
高庆军,王南鹏,周彦, 等. 甲状腺乳头状癌颈部淋巴结转移规律及影响因素分析[J].中国普外基础与临床杂志, 2013, 20(3): 303-309.
[15]
Sun SP, Zhang Y, Cui ZQ, et al. Clinical application of carbon nano particle lymph node tracer in the VI region lymph node dissection of differentiated thyroid cancer[J]. Genet Mol Res, 2014, 13(2): 3432-3437.
[16]
叶轲,李新营,常实, 等. 纳米炭在腔镜下甲状腺癌手术中的临床应用[J]. 中国普通外科杂志, 2016, 25(5): 653-658.
[17]
杜俊峰,郝雪梅,季锡清, 等. 纳米碳示踪剂在甲状腺微小乳头状癌手术中的应用[J/CD]. 中华普外科手术学杂志(电子版), 2016, 10(5): 383-386.
[18]
张军,张永庆,张爱梅, 等. 纳米碳在甲状腺癌术中对甲状旁腺的保护作用[J]. 潍坊医学院报, 2016, 38(1): 70-72.
[19]
Khairy GA, AL-Saif A. Incidental parathyroidectomy during thyroid resection: incidence, risk factors, and outcome[J]. Ann Saudi Med, 2011, 31(3): 274-278.
[20]
朱精强,汪洵理,魏涛, 等. 纳米碳甲状旁腺负显影辨认保护技术在甲状腺癌手术中的应用[J]. 中国普外基础与临床杂志, 2013, 20 (9): 992-994.
[21]
LoPinto M, Rubio GA, Khan ZF, et al. Location of abnormal parathyroid glands: lessons from 810 parathyroidectomies[J]. J Surg Res, 2017, 207(10): 22-26.
[1] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[2] 麻紫月, 王贞文, 张强, 赵代伟, 张翊伦. 右侧喉不返神经1例报告[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 115-116.
[3] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[4] 田文. 甲状腺癌功能性根治颈淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 482-482.
[5] 王宇, 徐芳泉, 周旋, 姚晓峰, 李强. 不断提高分化型甲状腺癌根治性切除规范化[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 473-476.
[6] 孙辉, 李长霖. 分化型甲状腺癌根治性切除术中的关键考量与策略[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 477-481.
[7] 高一飞, 刘根祥, 孙长华, 周广军. 喉返神经监测在无充气腋窝入路腔镜单侧甲状腺切除+中央区淋巴结清扫术中的应用效果[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 483-486.
[8] 李云龙, 夏旭良, 江志强, 刘伟, 刘凯, 唐立, 刘昊中, 张思远. 三种方法治疗分化型甲状腺癌的临床疗效[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 487-489.
[9] 韩婧, 郝少龙, 康骅. 北京市单中心甲状腺癌患者临床特征的回顾分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 490-493.
[10] 何羽. 腔镜微创手术治疗分化型甲状腺癌的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 456-458.
[11] 宋红霞, 吴玩呈. 内镜下甲状腺手术切口入路发展的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(04): 470-472.
[12] 游涛建, 任林, 马宇. cT1-2N0期PTMC经口腔前庭入路腔镜甲状腺切除术后引流与否的可行性研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 311-314.
[13] 吴波, 郑永明, 杜世强. SPECT/CT及血清sTg水平预测甲状腺癌术后131I治疗患者淋巴结转移风险的价值分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(02): 212-216.
[14] 胡惠英, 高劲松. 妊娠合并甲状旁腺功能减退症的诊治[J/OL]. 中华产科急救电子杂志, 2024, 13(01): 13-17.
[15] 刘通, 李菲, 朱莹, 王蓓. 剪切波弹性成像对甲状腺癌术后放射性碘治疗损伤唾液腺腺体的评估[J/OL]. 中华诊断学电子杂志, 2024, 12(02): 80-84.
阅读次数
全文


摘要